GONUTS has been updated to MW1.31 Most things seem to be working but be sure to report problems.
PMID:16319058
Citation |
Bernier, M, Kwon, YK, Pandey, SK, Zhu, TN, Zhao, RJ, Maciuk, A, He, HJ, Decabo, R and Kole, S (2006) Binding of manumycin A inhibits IkappaB kinase beta activity. J. Biol. Chem. 281:2551-61 |
---|---|
Abstract |
IkappaB kinase (IKK) catalytic subunits play a key role in cytokinemediated nuclear factor (NF)-kappaB signaling, and a loss of NF-kappaB function appears to inhibit inflammation and oncogenesis. Manumycin A is a potent and selective farnesyltransferase inhibitor with antitumor activity. We found that manumycin A caused a rapid and potent inhibition of IKK activity induced by tumor necrosis factor alpha in a number of cell types. Most unexpectedly, other classes of farnesyltransferase inhibitors had no inhibitory effect. To identify the molecular mechanisms of manumycin A action, cultured human HepG2 hepatoma cells were transiently transfected with various IKKalpha and IKKbeta constructs, and a striking difference in manumycin A sensitivity was observed. Furthermore, cells expressing wild-type IKKbeta and IKKbeta mutated in the activation loop at Cys-179 exhibited covalent homotypic dimerization of IKKbeta in response to manumycin A, whereas substitution of Cys-662 and -716 conferred protection against dimer formation. Direct inhibition of IKK activity and formation of stable IKKbeta dimers were observed in the presence of manumycin A that could be blocked by dithiothreitol. IKK interaction with the adaptor protein IKKgamma/NEMO was disrupted in manumycin A-treated cells. Most importantly, administration of manumycin A to mice xenografted with murine B16F10 tumors caused potent IKK-suppressive effects. Thus, manumycin A with its epoxyquinoid moieties plays an important regulatory function in IKK signaling through pathways distinct from its role as a protein farnesylation inhibitor. |
Links |
PubMed Online version:10.1074/jbc.M511878200 |
Keywords |
Amino Acid Substitution; Animals; Cell Line, Tumor; Dimerization; Humans; I-kappa B Kinase/antagonists & inhibitors; I-kappa B Kinase/genetics; Mice; Neoplasms, Experimental/drug therapy; Polyenes/pharmacology; Polyenes/therapeutic use; Polyunsaturated Alkamides; Protein Binding; Transfection; Tumor Necrosis Factor-alpha/pharmacology |
edit table |
Significance
Annotations
Gene product | Qualifier | GO ID | GO term name | Evidence Code | with/from | Aspect | Notes | Status |
---|---|---|---|---|---|---|---|---|
edit table |
See also
References
See Help:References for how to manage references in GONUTS.